Koninklijke Philips | PHG - Current Liabilities


Koninklijke Philips reported EUR7.43B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Abbott USD 18.38B 1.88B Mar/2026
Baxter International USD 3.81B 218M Sep/2026
Becton, Dickinson and Co. USD 9.4B 897M Jun/2026
Boston Scientific USD 6.43B 1.86B Jun/2026
Danaher USD 9.05B 945M Sep/2026
Demant DKK 12.42B 5B Jun/2026
Dexcom USD 2.25B 105.1M Sep/2026
Edwards Lifesciences USD 1.51B 98.9M Jun/2026
Fresenius EUR 9.07B 468M Jun/2026
General Electric Aerospace USD 42.4B 1.96B Sep/2026
Getinge SEK 12.03B 3.01B Jun/2026
Globus Medical USD 479.35M 3.12M Jun/2026
GN Store Nord DKK 5.97B 1.15B Jun/2026
Hitachi JPY 7.34T 175.94B Sep/2026
Idexx Laboratories USD 1.29B 12.19M Jun/2026
Insulet USD 744.2M 56.7M Jun/2026
Integra LifeSciences USD 329M 1.88M Sep/2026
Intuitive Surgical USD 3.23B 652.4M Sep/2026
J&J USD 55.46B 562M Sep/2026
Koninklijke Philips EUR 7.43B 1.39B Mar/2026
Medtronic USD 11.8B 141M Jun/2026
Philips EUR 7.42B 8M Jun/2026
ResMed USD 1.4B 43.9M Jun/2026
Smith & Nephew USD 2.05B 510M Jun/2026
Steris USD 1.28B 138.3M Jun/2026
Stryker USD 6.68B 369M Jun/2026
Teleflex USD 720.38M 7.67M Jun/2026
Terumo JPY 413.28B 127.46B Jun/2026
Zimmer Biomet Holdings USD 3.01B 149.2M Jun/2026